Lv0
0 积分 2021-08-02 加入
Association Between Daily Timing of Everolimus and Survival in High‐Risk HR +/ HER2 − Early Breast Cancer: A Sub‐Analysis of the UCBG‐UNIRAD Trial
12天前
已完结
Evaluating everolimus for the treatment of breast cancer
12天前
已完结
Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of KEYNOTE-426
18天前
已完结
Efficacy of fruquintinib (F) plus sintilimab (S) versus axitinib (A) or everolimus (E) by scores of IMDC risk factors and PD-L1 expression at baseline in previously treated advanced renal cell carcinoma (RCC): A subgroup analysis of the FRUSICA-2 study
18天前
已关闭
Efficacy of fruquintinib (F) plus sintilimab (S) versus axitinib (A) or everolimus (E) by scores of IMDC risk factors and PD-L1 expression at baseline in previously treated advanced renal cell carcinoma (RCC): A subgroup analysis of the FRUSICA-2 study
18天前
已关闭
Iron overload: The achilles heel of β-thalassemia
18天前
已完结
Downstaging and R0 resection of initially unresectable metastatic well-differentiated grade-3 pancreatic neuroendocrine tumor: a case report
19天前
已完结
Real‐world effectiveness of adjuvant octreotide therapy in patients with pancreatic neuroendocrine tumors at high recurrence risk: A multicenter retrospective cohort study
19天前
已完结
A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors
19天前
已完结
Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
25天前
已关闭
皖公网安备34019202002308
